/ Print /

Matthew Majewski
Three Pricing Models That Address the High-Cost Gene, Cell Therapies
Three Pricing Models That Address the High-Cost Gene, Cell Therapies
Here are three innovative structures in pricing models to address the high-cost of curative therapies.